Mr. Daniel Delaney is the President and Chief Executive Officer of TECHLAB. Delaney is an accomplished executive in the medical technology and diagnostics industry, with decades of operating and commercial experience.
Prior to TECHLAB, Delaney was an Operating Partner with Pharos Capital; President of Viracor-IBT Laboratories; an operator of clinical diagnostic laboratories; and he served as the Chief Operating Officer of AccuVein, a breakthrough vascular imaging company where he led the operations and commercial organization. Before Accuvein, Delaney was Senior Vice President at Alere (now Abbott Rapid Diagnostics) after having served as President of Alere North America, where he achieved success in leading growth and profitability in two major business units (Acute Care and Physicians Diagnostics). While at Alere, Delaney served on the Board of Directors of TECHLAB.
Delaney had a successful 20 year career with Abbott Laboratories, including 18 years at Abbott Diagnostics. At Abbott, he held various roles of increasing responsibility, including Business Unit Director, Infusion Therapy (Hospira and Abbott Hospital Products Division), Marketing Director, Immunoassay, and other key leadership roles within the commercial organization of Abbott Diagnostics Division.
Delaney obtained his MBA in Marketing and Finance from the City University of New York, Baruch College, Zicklin School of Business and has a Bachelor’s Degree in Business and Economics from Saint Anselm College in Manchester, New Hampshire.